Nutrien (NYSE:NTR) Releases Quarterly Earnings Results, Misses Estimates By $0.13 EPS

by · The Markets Daily

Nutrien (NYSE:NTR – Get Free Report) announced its quarterly earnings data on Wednesday. The company reported $0.61 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.74 by ($0.13), Briefing.com reports. Nutrien had a return on equity of 8.88% and a net margin of 8.44%. During the same period in the previous year, the firm earned $0.97 earnings per share. The firm’s revenue for the quarter was up .9% compared to the same quarter last year.

Nutrien Stock Performance

Shares of NTR traded up $2.73 during trading hours on Wednesday, hitting $72.05. The stock had a trading volume of 3,439,787 shares, compared to its average volume of 2,338,140. The company has a debt-to-equity ratio of 0.36, a quick ratio of 0.86 and a current ratio of 1.39. The firm has a 50-day moving average price of $72.92 and a 200 day moving average price of $71.06. Nutrien has a fifty-two week low of $53.65 and a fifty-two week high of $85.36. The firm has a market capitalization of $34.24 billion, a price-to-earnings ratio of 14.81, a PEG ratio of 0.77 and a beta of 0.67.

Nutrien News Summary

Here are the key news stories impacting Nutrien this week:

  • Positive Sentiment: Revenue was $6.06 billion, topping the $5.76 billion FactSet estimate, and Nutrien declared a quarterly dividend of US$0.55 per share. Revenue report Dividend announcement
  • Neutral Sentiment: The company reported $1.31 billion in adjusted EBITDA and said it generated $4.85 billion in adjusted EBITDA over the first nine months of the year. Third-quarter results
  • Negative Sentiment: Adjusted earnings per share were $0.61, below the $0.74 consensus and down from $0.97 a year earlier. Net profit fell 39% to about $290 million, despite the revenue beat. Earnings estimate comparison Profit decline report
  • Negative Sentiment: Reports cited higher sulfur costs and a phosphate business downturn as factors behind the earnings shortfall. Nutrien also plans to close its Florida plant, adding to concerns about near-term operating pressures. Costs and Florida plant report

Analyst Upgrades and Downgrades

Several brokerages recently weighed in on NTR. Freedom Broker started coverage on shares of Nutrien in a report on Tuesday, October 27th. They issued a “hold” rating and a $78.00 price target on the stock. Canadian Imperial Bank of Commerce restated an “outperform” rating on shares of Nutrien in a research note on Monday, August 10th. BNP Paribas Exane raised shares of Nutrien from a “neutral” rating to an “outperform” rating and set a $80.00 price objective on the stock in a report on Tuesday, July 28th. UBS Group upped their price objective on shares of Nutrien from $59.00 to $62.00 and gave the company a “sell” rating in a report on Tuesday, October 27th. Finally, National Bank Financial cut their price objective on shares of Nutrien from $76.00 to $74.00 and set an “outperform” rating on the stock in a research note on Monday, August 10th. Sixteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $79.24.

Check Out Our Latest Stock Report on NTR

Nutrien Company Profile

(Get Free Report)

Featured Stories